Safety and Efficacy Assessment of HAV (Manufactured Using Large-scale System) in Patients Needing Vascular Access for Dialysis
Conditions: Renal Failure; End Stage Renal Disease; Vascular Access; Hemodialysis Intervention: Biological: HAV Sponsor: Humacyte, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials